Cladribine as a therapeutic option in multiple sclerosis

被引：10

作者：

Warnke, Clemens ^{[1
]}

Leussink, Verena I. ^{[1
]}

Goebels, Norbert ^{[1
]}

Aktas, Orhan ^{[1
]}

Boyko, Alexey ^{[2
,3
]}

Kieseier, Bernd C. ^{[1
]}

Hartung, Hans-Peter ^{[1
]}

机构：

[1] Univ Dusseldorf, Dept Neurol, Fac Med, D-40225 Dusseldorf, Germany

[2] Russian State Med Univ, Dept Neurol & Neurosurg, Moscow 117437, Russia

[3] Moscow MS Ctr, Moscow, Russia

来源：

CLINICAL IMMUNOLOGY | 2012年 / 142卷 / 01期

关键词：

Cladribine; Multiple sclerosis; Immunosuppressant; Oral drugs; DOUBLE-BLIND; 2-CHLORODEOXYADENOSINE; TOXICITY; 2-CHLORO-2'-DEOXYADENOSINE; APOPTOSIS; TABLETS; SAFETY; CELLS; TRIAL;

D O I：

10.1016/j.clim.2011.05.009

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

There is an unmet need for more potent and convenient drugs in the treatment of patients diagnosed with multiple sclerosis (MS). Among five currently investigated oral drugs with an ongoing or completed phase III program, promising efficacy data for oral cladribine have recently been published. However, benefits need to be weighed against potential risks to define the role of this compound within current treatment regimens. Here we review present data on efficacy of oral cladribine and discuss known and anticipated risks of this drug. (C) 2011 Published by Elsevier Inc.

引用

页码：68 / 75

页数：8

共 50 条

[1] Luteolin as a therapeutic option for multiple sclerosis
Theoharis C Theoharides
Journal of Neuroinflammation, 6
[2] Luteolin as a therapeutic option for multiple sclerosis
Theoharides, Theoharis C.
JOURNAL OF NEUROINFLAMMATION, 2009, 6
[3] MULTIPLE SCLEROSIS Cladribine-a contentious therapeutic contender for MS
Hohlfeld, Reinhard
NATURE REVIEWS NEUROLOGY, 2011, 7 (08) : 425 - 427
[4] Nanodelivery of myelin: A therapeutic option for multiple sclerosis
Dharamkar, Anil Kumar Chandramohan
MEDICAL HYPOTHESES, 2008, 71 (02) : 318 - 319
[5] Statins in multiple sclerosis: a new therapeutic option?
Neuhaus, O
Archelos, JJ
Hartung, HP
MULTIPLE SCLEROSIS JOURNAL, 2003, 9 (05) : 429 - 430
[6] Natalizumab as new therapeutic option for multiple sclerosis
Linker, R. A.
Hohlfeld, R.
Gold, R.
AKTUELLE NEUROLOGIE, 2008, 35 (02) : 89 - 96
[7] Intravenous immunoglobulins as therapeutic option in the treatment of multiple sclerosis
Ales Dudesek
Uwe K. Zettl
Journal of Neurology, 2006, 253 : v50 - v58
[8] Intravenous immunoglobulins as therapeutic option in the treatment of multiple sclerosis
Dudesek, Ales
Zettl, Uwe K.
JOURNAL OF NEUROLOGY, 2006, 253 (Suppl 5) : 50 - 58
[9] Cladribine (Mavenclad) for Multiple Sclerosis
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2019, 61 (1577): : 118 - 120
[10] Oral cladribine for multiple sclerosis
Ellison, GW
Myers, LW
NEUROLOGY, 1997, 48 (03) : 3070 - 3070

← 1 2 3 4 5 →